Treatment Outcome of Olfactory Neuroblastoma: A Multicenter Study by the Korean Sinonasal Tumor and Skull Base Surgery Study Group
CONCLUSION: Clinical staging and pathologic grading are important prognostic factors in ONB. Dural resection in mKadish A and B did not show a significant survival benefit. Induction chemotherapy did not show a survival benefit, even after stage matching.PMID:38404243 | DOI:10.21053/ceo.2023.00089
Source: Clinical and Experimental Otorhinolaryngology - Category: ENT & OMF Authors: Sang Duk Hong Song I Park Ji Heui Kim Sung Jae Heo Sung-Woo Cho Tae-Bin Won Hyun-Jin Cho Dong Hoon Lee Sue Jean Mun Soo Kyoung Park Yong-Wan Kim Dong-Young Kim Source Type: research
More News: Brain | Cancer & Oncology | Chemotherapy | ENT & OMF | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Neuroblastoma | Neurology | Neurosurgery | South Korea Health | Statistics | Study